Literature DB >> 26758291

Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma.

Hyoung Shin Lee1, Chanwoo Park1, Sung Won Kim1, Woong Jae Noh1, Soo Jin Lim2, Bong Kwon Chun3, Beom Su Kim4, Jong Chul Hong5, Kang Dae Lee6,7.   

Abstract

The importance of pathologic features of metastatic lymph nodes (LNs), such as size, number, and extranodal extension, has been recently emphasized in patients with papillary thyroid carcinoma (PTC). We evaluated the characteristics of metastatic LNs identified after prophylactic central neck dissection (CND) in patients with PTC. We performed a retrospective review of 1,046 patients who underwent unilateral or bilateral thyroidectomy with ipsilateral prophylactic CND. We reviewed the characteristics of the metastatic LNs and analyzed their correlation to the clinicopathologic characteristics of the primary tumor. Cervical LN metastasis after prophylactic CND was identified in 280 out of 1046 patients (26.8 %). The size of metastatic foci (≥2 mm) was independently correlated with primary tumor size (≥1 cm) (p = 0.016, OR = 1.88). Primary tumor size (≥1 cm) was also correlated to the number of metastatic LNs (≥5) (p = 0.004, OR = 3.14) and extranodal extension (p = 0.021, OR = 2.41) in univariate analysis. The size of the primary tumor affects pathologic features of subclinical LN metastasis in patients with PTC. Patients with primary tumors ≥1 cm have an increased risk of larger LN metastases (≥2 mm), an increased number of LN metastases (≥5), and a higher incidence of ENE, which should be considered in decision for prophylactic CND.

Entities:  

Keywords:  Lymph nodes; Lymphatic metastasis; Papillary thyroid carcinoma; Pathology

Mesh:

Year:  2016        PMID: 26758291     DOI: 10.1007/s00405-015-3881-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  38 in total

1.  Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.

Authors:  David T Hughes; Matthew L White; Barbra S Miller; Paul G Gauger; Richard E Burney; Gerard M Doherty
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

2.  Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

3.  Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.

Authors:  Laura Y Wang; Frank L Palmer; Iain J Nixon; Dorothy Thomas; Jatin P Shah; Snehal G Patel; R Michael Tuttle; Ashok R Shaha; Ian Ganly
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  Extent of central neck dissection among thyroid cancer surgeons: Cross-sectional analysis.

Authors:  Michael W Deutschmann; Laura Chin-Lenn; Jennifer Au; Alan Brilz; Steve Nakoneshny; Joseph C Dort; Janice L Pasieka; Shamir P Chandarana
Journal:  Head Neck       Date:  2015-05-26       Impact factor: 3.147

5.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

6.  Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis.

Authors:  Min Ji Jeon; Won Gu Kim; Yun Mi Choi; Hyemi Kwon; Dong Eun Song; Yu-Mi Lee; Tae-Yon Sung; Jong Ho Yoon; Suck Joon Hong; Jung Hwan Baek; Jeong Hyun Lee; Jin-Sook Ryu; Tae Yong Kim; Young Kee Shong; Ki-Wook Chung; Won Bae Kim
Journal:  J Clin Endocrinol Metab       Date:  2015-06-29       Impact factor: 5.958

7.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

8.  Impact of lymph node ratio on survival in papillary thyroid cancer.

Authors:  David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344

9.  Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence.

Authors:  Jeonghun Lee; Youngpeck Song; Euy Young Soh
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

10.  Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

View more
  1 in total

1.  Prophylactic bilateral central neck dissection should be evaluated based on prospective randomized study of 581 PTC patients.

Authors:  Shouyi Yan; Jiafan Yu; Wenxin Zhao; Bo Wang; Liyong Zhang
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.